Mental Health Clinics in Ogdensburg, NJ Accepting Medicare
2 Mental Health Clinics found. Showing 1 - 2
 Mjci Institute, Inc. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 190 Main St, Ogdensburg, NJ 07439 Phone: 973-726-4809 |
Mjc Institute, Inc Psychologist Medicare: Medicare Enrolled Practice Location: 190 Main St, Ogdensburg, NJ 07439 Phone: 973-827-2300 Fax: 973-827-2300 |
News Archive
Improved risk classification for patients with acute lymphoblastic leukemia offers hope for eliminating irradiation
Improved risk classification for patients with acute lymphoblastic leukemia (ALL), coupled with more intensive intrathecal chemotherapy for high risk patients and the use of a drug called dexamethasone, could one day permit physicians to omit irradiation as a part of routine treatment.
WHO urges responsible use of antimalarial medicines
In a new report published today, ''Susceptibility of Plasmodium Falciparum to Antimalarial Drugs,'' the World Health Organization (WHO) warns that as more and more people gain access to these life-saving malaria medicines, which combine a drug derived from the plant Artemisia annua with a second, synthetic drug, it is vital that countries closely monitor their effectiveness.
Obama campaign contributors being asked to donate to effort supporting health care reform
The Washington Times on Friday examined how President Obama's "former campaign apparatus is cranking up a full-tilt drive for passage of a health care overhaul this year" by "tapping his 13-million-strong e-mail list" for financial contributions to fund advertising efforts, hire staff and open election-style offices.
Gout gene discovered
Having partnered last year with an international team that surveyed the genomes of 12,000 individuals to find a genetic cause for gout, Johns Hopkins scientists now have shown that the malfunctioning gene they helped uncover can lead to high concentrations of blood urate that forms crystals in joint tissue, causing inflammation and pain - the hallmark of this disease.
Gilead Sciences signs definitive agreement to acquire CGI Pharmaceuticals
Gilead Sciences, Inc. and CGI Pharmaceuticals, Inc., a privately-held, development-stage pharmaceutical company focused on small molecule chemistry and kinase biology, today announced the signing of a definitive agreement pursuant to which Gilead will acquire CGI. Under the terms of the agreement, Gilead will acquire CGI for up to $120 million, the majority as an upfront payment and the remaining based on clinical development progress, all of which will be financed through available cash on hand.
› Verified 9 days ago